Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15269840rdf:typepubmed:Citationlld:pubmed
pubmed-article:15269840lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C0108747lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C1367477lld:lifeskim
pubmed-article:15269840lifeskim:mentionsumls-concept:C1414555lld:lifeskim
pubmed-article:15269840pubmed:issue2lld:pubmed
pubmed-article:15269840pubmed:dateCreated2004-7-22lld:pubmed
pubmed-article:15269840pubmed:abstractTextMonocytes play a central role in the inflammatory disease atherosclerosis. CD14+CD16+ monocytes are considered proinflammatory monocytes, as they have an increased capacity to produce proinflammatory cytokines, such as TNF-alpha, and are elevated in various inflammatory diseases. We hypothesized that patients with coronary artery disease (CAD) have increased levels of CD14+CD16+ monocytes, and that CD14+CD16+ monocytes are associated with inflammation markers. We investigated CD14+CD16+ monocytes in 247 patients with CAD and 61 control subjects using flow cytometry. In addition serum concentrations of TNF-alpha, IL-6, and Hs-CRP were assessed. Patients with CAD had higher levels of CD14+CD16+ monocytes than controls (13.6% versus 11.4%; p<0.001). Logistic regression analysis including quartiles of CD14+CD16+ monocytes showed that CD14+CD16+ monocytes were associated with prevalence of CAD (OR 4.9, 95% CI 2.5-19.1, for subjects in the fourth quartile in comparison to subjects in the first quartile). The association between CD14+CD16+ monocytes and CAD remained independently significant after adjustment for most potential confounders (OR 5.0, 95% CI 1.2-20.0). Serum concentrations of TNF-alpha were elevated in subjects within the highest quartiles of CD14+CD16+ monocytes (p=0.018). Our study showed that increased numbers of CD14+CD16+ monocytes are associated with coronary atherosclerosis and TNF-alpha. In accordance, recent animal studies suggest a possibly important role of these monocytes in the development of atherosclerosis.lld:pubmed
pubmed-article:15269840pubmed:languageenglld:pubmed
pubmed-article:15269840pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:citationSubsetIMlld:pubmed
pubmed-article:15269840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15269840pubmed:statusMEDLINElld:pubmed
pubmed-article:15269840pubmed:monthAuglld:pubmed
pubmed-article:15269840pubmed:issn0340-6245lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:Espinola-Klei...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:RupprechtHans...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:BlankenbergSt...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:BickelChristo...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:DariusHaraldHlld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:MeyerJuergenJlld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:SchlittAxelAlld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:LacknerKarl...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:HeineGunnar...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:DopheideJoern...lld:pubmed
pubmed-article:15269840pubmed:authorpubmed-author:IzMeteMlld:pubmed
pubmed-article:15269840pubmed:issnTypePrintlld:pubmed
pubmed-article:15269840pubmed:volume92lld:pubmed
pubmed-article:15269840pubmed:ownerNLMlld:pubmed
pubmed-article:15269840pubmed:authorsCompleteYlld:pubmed
pubmed-article:15269840pubmed:pagination419-24lld:pubmed
pubmed-article:15269840pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:meshHeadingpubmed-meshheading:15269840...lld:pubmed
pubmed-article:15269840pubmed:year2004lld:pubmed
pubmed-article:15269840pubmed:articleTitleCD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.lld:pubmed
pubmed-article:15269840pubmed:affiliationDepartment of Medicine II and Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University, Mainz, Germany. axelschlitt@gmx.netlld:pubmed
pubmed-article:15269840pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:929entrezgene:pubmedpubmed-article:15269840lld:entrezgene
entrez-gene:2214entrezgene:pubmedpubmed-article:15269840lld:entrezgene
entrez-gene:7124entrezgene:pubmedpubmed-article:15269840lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15269840lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15269840lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15269840lld:entrezgene
lhgdn:association:41322lhgdn:found_inpubmed-article:15269840lld:lhgdn
lhgdn:association:47865lhgdn:found_inpubmed-article:15269840lld:lhgdn
lhgdn:association:62367lhgdn:found_inpubmed-article:15269840lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15269840lld:pubmed